This page lists 74 FDA decision dates covering June 2026 to December 2026. 57 are still ahead, and 16 have been decided and are marked with the outcome. 1 passed its target date without a published decision. Each date comes from an FDA notice or a company filing, and where the source gives only a month or a quarter we say so instead of inventing a day.
Every upcoming FDA decision (PDUFA) date, drug, company, indication, run-up history, and market-cap cohort base rates. Tap any name for the full facts.
Put this calendar in your calendar
448 catalysts, refreshed daily. Free, and no account needed.
Subscribing keeps it current: new dates and changes arrive automatically. 121 entries have a confirmed date and appear on that single day. 327 are guided only to a month or quarter, so they span that whole window and are prefixed with ~. We do not place an estimate on a specific day, because in a calendar app a guess looks exactly like a confirmed FDA date.
Run-up context, measured from a uniform T-120 baseline. Across 1,833 FDA decisions since 2020, the median peak gain from 120 trading days out was 17.8%, while the median move from T-120 to the day before the decision was 1.9%. The gap between those two numbers is the point: most of the move happens before the decision and is usually given back. 96% of events have a full T-120 window; the rest are excluded rather than back-filled. Full study. Past behaviour, not a forecast, and not investment advice.